Ginkgo Bioworks Holdings (DNA) Revenue Growth (5y) (2025 - 2026)

Ginkgo Bioworks Holdings (DNA) Revenue Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,019.86 Bn	66,019.58 Bn	-
2	Nanobiotix	1,909.20 Bn	1,909.14 Bn	-
3	Akari Therapeutics	1,009.43 Bn	1,009.43 Bn	-
4	BeOne Medicines	468.20 Bn	463.41 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.50 Bn	115.26 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.15 Bn	61.39 Bn	3.31 Bn
7	Belite Bio	62.66 Bn	62.66 Bn	-
8	Argenx Se	55.58 Bn	50.39 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.43 Bn	34.43 Bn	959.66 Mn
10	Ginkgo Bioworks Holdings	438.98 Mn	295.12 Mn	16.38 Mn

Download Data